VIVOS THERAPEUTICS, INC. (VVOS) Operating income 2019–2025
VIVOS THERAPEUTICS, INC. (VVOS) annual operating income history from SEC filings — each fiscal year as reported.
-$19.9MFY2025 · since FY2019: -$10.6M → -$19.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.9M | -78.1% |
| FY2024 | -$11.2M | +35.4% |
| FY2023 | -$17.3M | +30.9% |
| FY2022 | -$25.0M | -22.8% |
| FY2021 | -$20.4M | -69.3% |
| FY2020 | -$12.0M | -13.8% |
| FY2019 | -$10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross profitVVOS Gross marginVVOS Operating marginVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Return on equityVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →